The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 29 | 62.1x | 20.1x | Below average | |
Growth | 25 | -4.4% | 5.6% | Below average | |
Quality | 61 | 9.2% | 7.6% | Near average | |
Safety | 65 | 0.1x | 0.4x | Near average | |
Capital Return | 73 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | 40 | — | — | Near average |
Horizon Therapeutics Public Limited Company is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Horizon Therapeutics Public Limited Company shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
HZNP stock shows a state of artificial price stability at a consensus level of $127.15, yet details indicate a notable decline in analyst coverage, as the number of active analysts dropped from 12 to only 5. This contraction in the number of opinions reflects a state of certainty regarding the target price, often associated with acquisition or merger conditions, causing forecasts to converge within a narrow range between $110 and $144.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.